Applied DNA Sciences : Q&A with Dr. Stephen Hughes, Director of DNA Programs
July 20, 2018 at 02:18 pm EDT
Share
Dr. Hughes has more than 20 years experience working with engineers and scientists at universities, industries, and government institutions to implement molecular biology techniques, develop improved genes and cell lines, create novel vectors for expressing genes and DNA constructs, provide support for screening synthetic genes, and assist in designing integrated automated platforms for these operations. Most recently, Dr. Hughes built the first-in-kind integrated robotic platform to perform high-throughput cloning, transformation, expression and assay operations for screening synthetic genes to use in improving industrial yeast strains for bioenergy production. He created innovative efficient high-throughput microbial gene expression systems combined with novel gene/chromosome synthesis approaches for automated platforms to create improved microbial strains. These projects all required an in-depth knowledge of DNA technology. Dr. Hughes has a doctoral degree in molecular genetics, biochemistry, and microbiology, with an undergraduate degree in molecular biology and genetics.
Attachments
Original document
Permalink
Disclaimer
Applied DNA Sciences Inc. published this content on 20 July 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 20 July 2018 18:17:03 UTC
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Companyâs proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Companyâs Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.